Drug
Low dose ketamine
Low dose ketamine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 33.3%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
2(67%)
Phase Distribution
Ph phase_4
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 42 (66.7%)
Trials by Status
completed133%
terminated267%
Recent Activity
0 active trials
Showing 3 of 3
terminatedphase_4
Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the ED
NCT05422001
completedphase_4
Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers
NCT02434939
terminatedphase_3
Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine
NCT00224692
Clinical Trials (3)
Showing 3 of 3 trials
NCT05422001Phase 4
Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the ED
NCT02434939Phase 4
Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers
NCT00224692Phase 3
Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3